COMPARISON OF IDARUBICIN VS EPIDOXORUBICIN-CONTAINING PROMACE-CYTABOMREGIMENS IN UNTREATED AGGRESSIVE NON-HODGKINS-LYMPHOMA (NHL) - FINAL RESULTS OF A MULTICENTER RANDOMIZED TRIAL OF THE ITALIAN LYMPHOMA STUDY-GROUP (GISL)
M. Brugiatelli et al., COMPARISON OF IDARUBICIN VS EPIDOXORUBICIN-CONTAINING PROMACE-CYTABOMREGIMENS IN UNTREATED AGGRESSIVE NON-HODGKINS-LYMPHOMA (NHL) - FINAL RESULTS OF A MULTICENTER RANDOMIZED TRIAL OF THE ITALIAN LYMPHOMA STUDY-GROUP (GISL), Blood, 90(10), 1997, pp. 840-840